Search Results for keywords:"Norac Pharma"

Found 2 results

Search Results: keywords:"Norac Pharma"

💰 Only
Oldest Newest
  • 2025-03062 — Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma
    Type:Notice
    Citation:90 FR 10732
    Reading Time:about a minute or two

    S&B Pharma LLC DBA Norac Pharma has submitted an application to the Drug Enforcement Administration (DEA) to register as an importer of certain controlled substances. The company intends to import intermediate forms of Tapentadol for further manufacturing and ANPP for producing other controlled substances. Public comments or objections to this application can be submitted electronically by March 28, 2025. The DEA will only approve import permits if the company's activities comply with specific federal regulations.

    Simple Explanation

    S&B Pharma wants permission from a special U.S. agency to bring in certain powerful medicine ingredients from other countries to make new medicines. People can tell the agency if they think this is okay or not until almost the end of March 2025.

  • 2021-00326 — Importer of Controlled Substances Application: S&B Pharma LLC dba Norac Pharma
    Type:Notice
    Citation:86 FR 2458
    Reading Time:about a minute or two

    S&B Pharma LLC, also known as Norac Pharma, has submitted an application to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. The company plans to import these substances in bulk to manufacture other controlled drugs for its customers. The public can submit comments or request a hearing regarding this application until February 11, 2021. All submissions should be sent to the DEA offices in Springfield, Virginia.

    Simple Explanation

    S&B Pharma LLC wants permission to bring in some special medicines to use in making other medicines. People can tell the government if they don't like this idea until February 11, 2021.